CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)	3 Months Ended		6 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Operating expenses:
Research and development	$ 1,656,100	$ 557,600	$ 2,028,700	$ 1,031,200
General and administrative	3,730,500	556,100	5,179,000	1,353,300
Total operating expenses	5,386,600	1,113,700	7,207,700	2,384,500
Loss from operations	(5,386,600)	(1,113,700)	(7,207,700)	(2,384,500)
Other expenses, net:
Interest expense, net	$ (12,200)	(605,600)	(767,300)	(1,390,500)
Change in warrant liability		1,301,800	(1,894,700)	(425,400)
Loss on extinguishment of debt	$ (1,649,300)	(1,603,400)	(26,700,200)	(2,371,400)
Loss before income taxes	$ (7,048,100)	$ (2,020,900)	(36,569,900)	(6,571,800)
Income taxes			(2,300)	(2,400)
Net loss and comprehensive loss	$ (7,048,100)	$ (2,020,900)	(36,572,200)	$ (6,574,200)
Accrued dividends on Series B Preferred stock	(614,700)		(828,000)
Deemed dividend on Series B Preferred Units	(886,900)		(1,143,100)
Net loss attributable to common stockholders	$ (8,549,700)	$ (2,020,900)	$ (38,543,300)	$ (6,574,200)
Basic net loss attributable to common stockholders per common share	$ (5.26)	$ (1.58)	$ (24.21)	$ (5.24)
Diluted net loss attributable to common stockholders per common share	$ (5.26)	$ (1.90)	$ (24.21)	$ (5.24)
Weighted average shares used in computing basic net loss attributable to common stockholders per common share	1,624,371	1,279,251	1,592,104	1,254,506
Weighted average shares used in computing diluted net loss attributable to common stockholders per common share	1,624,371	1,299,099	1,592,104	1,254,506